GL1X · GenesisL1 explorer

Research workbench

Crystal structure of BRUTON'S tyrosine kinase in complex with inhibitor CGI2625

Analyse Crystal structure of BRUTON'S tyrosine kinase in complex with inhibitor CGI2625 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AUA
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase btk
EC
2.7.10.2
UniProt
Q06187
Ligands
BXJ, SO4
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase btk (EC 2.7.10.2)protein26544% helix, 17% strandQ06187

Ligands and binding sites

  • BXJ · N-{3-[(2R)-6-{[3-amino-4-(morpholine-4-carbonyl) phenyl]amino}-5-oxo-2,5-dihydropyrazin-2-yl]-2-methylphenyl}-4-(piperidin-1-yl)benzamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13470.660.8039BXJ
2660.540.8719GOL

Compared structures

  • 6AUA · Crystal structure of BRUTON'S tyrosine kinase in complex with inhibitor CGI2625 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.